Ignite Creation Date:
2025-12-24 @ 6:34 PM
Ignite Modification Date:
2025-12-29 @ 12:36 AM
Study NCT ID:
NCT06411457
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-16
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-04
First Submit QC Date:
None
Study First Post Date:
2024-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-15
Last Update Post Date:
2024-05-17
Last Update Post Date Type:
ACTUAL